Cupid reported a Q1 FY27 net profit of ₹44 crore, three times the previous year's figure, driving its shares up 8.8% in just two days. The company raised its FY27 revenue guidance to ₹725‑750 crore and net profit to ₹210‑225 crore.

Key Takeaways

  • Q1 FY27 net profit surged to ₹44 crore, three‑fold increase YoY.
  • Revenue jumped 159% to ₹155 crore.
  • FY27 guidance lifted: revenue ₹725‑750 crore, net profit ₹210‑225 crore.

Main News

Cupid shares rose 8.8% over two days, closing at ₹289.95 on the BSE, after the contraceptive‑maker posted a three‑times rise in net profit for the April‑June quarter of FY27.

Financial Performance

The company posted a consolidated net profit of ₹44 crore for Q1 FY27, compared with ₹15 crore in the same quarter last year. Operating revenue surged 159% YoY to ₹155 crore, while EBITDA grew 265% YoY to ₹60 crore, improving the EBITDA margin by 1,127 basis points to 39%.

Read Also:Bangladesh: PM Tarique Rahman Conducts Late-Night Inspection of Dhaka Streets

Historical Background

Over the past two years, Cupid has consistently delivered double‑digit growth in both revenue and earnings, cementing its status as a multibagger stock. In 2026, the share price rose 150% year‑to‑date, delivering a 10,979% return over five years.

Future Outlook

The firm implemented a minimum 10% price increase across its export portfolio, boosting realizations and margin expansion. Backed by a strong order book, an expanding consumer‑healthcare and FMCG portfolio, and robust international B2B demand, Cupid raised its FY27 guidance.

Why This Matters

BozokMedia analysis shows that Cupid’s rapid earnings acceleration and expanding global footprint position it as a pivotal player in India’s healthcare sector, enhancing its appeal to investors.

"Cupid’s Q1 results not only highlight operational excellence but also signal fresh growth avenues for India’s export‑driven health‑care industry," said financial analyst Anita Sharma.
Did You Know?: Cupid secured CE certification in 2024, unlocking significant expansion potential in European markets.

Frequently Asked Questions

Q1: Will Cupid’s shares continue to rise?

A: Analysts project a positive medium‑to‑long‑term outlook, citing the strong order pipeline and international expansion.

Q2: How will the new price hikes affect shareholders?

A: The price increase is expected to improve margins, supporting sustainable profit growth.